Compared with normal tissues, TOP2A mRNA is significantly expressed in bladder cancer, head and central nervous system cancer, breast cancer, cervical cancer, colorectal cancer, and other cancers. This evidence concerns the gene TOP2A and urinary bladder carcinoma.